TRxADE HEALTH, Inc.
NASDAQ: MEDS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Surendra K. Ajjarapu
- Employees
- 8
- Headquarters
- Land O'Lakes, United States
- IPO year
- 2014
- Market cap
- $13.3M
- Website
- https://www.trxadehealth.com
Loading MEDS…
Loading profile data…Frequently asked questions about MEDS
What does TRxADE HEALTH, Inc. (MEDS) do?
TRxADE HEALTH, Inc. operates as a healthcare technology firm within the United States. Its central aim is to modernize the retail pharmacy landscape by digitally enhancing drug acquisition, the prescription journey, and patient interactions. The company manages the TRxADE marketplace, a platform that promotes pricing clarity for pharmaceutical p...
Where does MEDS trade?
TRxADE HEALTH, Inc. (MEDS) trades on the NASDAQ Capital Market.
What sector is MEDS in?
TRxADE HEALTH, Inc. (MEDS) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of TRxADE HEALTH, Inc.?
Surendra K. Ajjarapu is the chief executive officer of TRxADE HEALTH, Inc. (MEDS).
Where is TRxADE HEALTH, Inc. headquartered?
TRxADE HEALTH, Inc. is headquartered in United States.
Does MEDS pay a dividend?
Yes — TRxADE HEALTH, Inc. (MEDS) paid a trailing twelve-month dividend of USD 9.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did MEDS go public?
TRxADE HEALTH, Inc. (MEDS) completed its initial public offering in 2014.